Medicine
Letrozole 2.5 mg tablet
Letrozole 2.5 mg tablet is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Letrozole
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets, 10 blister pack and 38 more
- Manufacturers
- Accord HealthcareIndiaAurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaNatco PharmaIndiaBryant Ranch PrepackBreckenridge PharmaceuticalA-S Medication SolutionsAvKARECarnegie PharmaceuticalsChartwell RX19 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BG04 Letrozole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 June 2011
- Identifiers
- RxCUI 200064DailyMed set ID 3baa3912-3e64-473b-8ec6-8557aa7907c2, 1524730f-e37d-478c-1956-b113b3ca42a8, 35c73219-c39e-4e10-b944-76009b061e79 +20NDC 50090-8002, 42291-374, 63850-0025 +20Application ANDA200161, ANDA090289, ANDA090934 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 19 labelers. The register lists 41 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 16729-034-10 | Accord HealthcareIndia | 2 June 2011 |
| 90 tablet, film coated in 1 bottle | 16729-034-15 | Accord HealthcareIndia | 31 December 2014 |
| 30 tablet, film coated in 1 bottle | 59651-180-30 | Aurobindo PharmaIndia | 11 January 2019 |
| 90 tablet, film coated in 1 bottle | 59651-180-90 | Aurobindo PharmaIndia | 11 January 2019 |
| 30 tablet, film coated in 1 bottle | 55111-646-30 | Dr. Reddy's LaboratoriesIndia | 3 June 2011 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 55111-646-78 | Dr. Reddy's LaboratoriesIndia | 3 June 2011 |
| 30 tablet in 1 bottle | 63850-0025-1 | Natco PharmaIndia | 3 June 2011 |
| 1000 tablet in 1 bottle | 63850-0025-4 | Natco PharmaIndia | 3 June 2011 |
| 1000 tablet in 1 bottle | 51991-759-10 | Breckenridge Pharmaceutical | 4 June 2011 |
| 30 tablet in 1 bottle | 51991-759-33 | Breckenridge Pharmaceutical | 4 June 2011 |
| 90 tablet in 1 bottle | 51991-759-90 | Breckenridge Pharmaceutical | 1 October 2022 |
| 30 tablet, film coated in 1 bottle, plastic | 80005-139-08 | Carnegie Pharmaceuticals | 30 June 2026 |
| 90 tablet, film coated in 1 bottle, plastic | 80005-139-10 | Carnegie Pharmaceuticals | 30 June 2026 |
| 30 tablet, film coated in 1 bottle | 62135-491-30 | Chartwell RX | 17 January 2022 |
| 90 tablet, film coated in 1 bottle | 62135-491-90 | Chartwell RX | 17 January 2022 |
| 30 tablet, film coated in 1 bottle | 0093-7620-56 | Teva Pharmaceuticals | 3 June 2011 |
| 90 tablet, film coated in 1 bottle | 24979-726-07 | Upsher-Smith Laboratories | 10 January 2025 |
| 30 tablet, film coated in 1 bottle | 63629-7819-1 | Bryant Ranch Prepack | 3 April 2026 |
| 10 tablet, film coated in 1 bottle | 63629-7819-2 | Bryant Ranch Prepack | 3 April 2026 |
| 90 tablet, film coated in 1 bottle | 63629-7819-3 | Bryant Ranch Prepack | 3 April 2026 |
| 40 tablet, film coated in 1 bottle | 63629-7819-4 | Bryant Ranch Prepack | 3 April 2026 |
| 30 tablet in 1 bottle | 71335-1526-1 | Bryant Ranch Prepack | 1 February 2021 |
| 10 tablet in 1 bottle | 71335-1526-2 | Bryant Ranch Prepack | 27 February 2020 |
| 90 tablet in 1 bottle | 71335-1526-3 | Bryant Ranch Prepack | 21 December 2022 |
| 40 tablet in 1 bottle | 71335-1526-4 | Bryant Ranch Prepack | 21 December 2022 |
| 30 tablet, film coated in 1 bottle | 71335-2396-1 | Bryant Ranch Prepack | 19 April 2024 |
| 10 tablet, film coated in 1 bottle | 71335-2396-2 | Bryant Ranch Prepack | 3 January 2025 |
| 90 tablet, film coated in 1 bottle | 71335-2396-3 | Bryant Ranch Prepack | 31 January 2025 |
| 40 tablet, film coated in 1 bottle | 71335-2396-4 | Bryant Ranch Prepack | 31 January 2025 |
| 90 tablet, film coated in 1 bottle | 50090-3474-0 | A-S Medication Solutions | 14 June 2018 |
| 90 tablet in 1 bottle | 50090-8002-0 | A-S Medication Solutions | 24 June 2026 |
| 40 tablet, film coated in 1 bottle | 68071-2167-4 | NuCare Pharmaceuticals,Inc | 19 June 2024 |
| 30 tablet, film coated in 1 bottle | 68071-5264-3 | NuCare Pharmaceuticals,Inc | 1 June 2020 |
| 100 pouch in 1 box, unit-dose / 1 tablet, film coated in 1 pouch | 17856-0032-1 | Atlantic Biologicals | 13 January 2020 |
| 30 tablet, film coated in 1 bottle | 42291-374-30 | AvKARE | 4 January 2024 |
| 90 tablet, film coated in 1 bottle | 42291-374-90 | AvKARE | 5 January 2015 |
| 50 blister pack in 1 box / 1 tablet in 1 blister pack | 50268-476-15 | AvPAK | 2 October 2019 |
| 90 tablet, film coated in 1 bottle | 51407-986-90 | Golden State Medical Supply | 20 February 2025 |
| 30 tablet, film coated in 1 bottle | 71205-587-30 | Proficient Rx | 7 July 2021 |
| 60 tablet, film coated in 1 bottle | 71205-587-60 | Proficient Rx | 7 July 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 July 1997 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Letrozole 2.5 mg tablet.
Clinical summary
Letrozole is an aromatase inhibitor indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Letrozole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LetrozoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Femara prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Letrozole 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.